Belite Bio (BLTE) Leases (2022 - 2025)
Belite Bio (BLTE) recorded quarterly Leases of $433000.0 in Q4 2025, down 14.93% quarter-over-quarter from $509000.0 in Q3 2025, and down 16.89% on a YoY basis from $521000.0 in Q4 2024.
Belite Bio (BLTE) Leases (2022 - 2025) Analysis & Trends
Belite Bio's Leases history runs 4 years deep, the most recent figure standing at $433000.0 for Q4 2025.
- In Q4 2025, Leases fell 16.89% year-over-year to $433000.0; the TTM figure through Dec 2025 stood at $433000.0 (down 16.89% YoY), while the FY2025 annual figure was $433000.0, down 16.89% from the prior year.
- Leases was $433000.0 for Q4 2025 at Belite Bio, down from $509000.0 in the prior quarter.
- In the past five years, Leases ranged from a high of $811000.0 in Q4 2023 to a low of $433000.0 in Q4 2025.
- Historically, Leases has averaged $616000.0 across 4 years, with a median of $521000.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Leases climbed 0.62% in 2023, then plunged 35.76% in 2024.
- A 4-year view of Leases shows it stood at $806000.0 in 2022, then grew by 0.62% to $811000.0 in 2023, then slumped by 35.76% to $521000.0 in 2024, then fell by 16.89% to $433000.0 in 2025.
- The last three Leases figures came in at $433000.0 (Q4 2025), $509000.0 (Q3 2025), and $521000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 61,822.50 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,048.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 285.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.69 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 433,000.00 |
| Sep 30, 2025 | 509,000.00 |
| Dec 31, 2024 | 521,000.00 |
| Dec 31, 2023 | 811,000.00 |
| Dec 31, 2022 | 806,000.00 |